Paul J Catalano
Harvard University
H-index: 76
North America-United States
Top articles of Paul J Catalano
PD-1 Expression on Intratumoral Regulatory T Cells Is Associated with Lack of Benefit from Anti–PD-1 Therapy in Metastatic Clear-Cell Renal Cell Carcinoma Patients
Clinical Cancer Research
2024/2/16
Emily Walton
H-Index: 15
Saurabh Gupta
H-Index: 25
Paul J Catalano
H-Index: 46
Sabina Signoretti
H-Index: 76
Tumor-infiltrating CD163-positive macrophages and clinical outcomes to first-line nivolumab therapy in patients with advanced clear cell renal cell carcinoma (ccRCC) enrolled …
2024/2/1
Large language models to identify social determinants of health in electronic health records
NPJ digital medicine
2024/1/11
Shan Chen
H-Index: 3
Spencer Thomas
H-Index: 7
Tafadzwa L Chaunzwa
H-Index: 4
Benjamin H Kann
H-Index: 12
Paul J Catalano
H-Index: 46
Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)
Journal for Immunotherapy of Cancer
2024
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292)
Annals of surgical oncology
2023/2
Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)
Journal for immunotherapy of cancer
2023
Mark Stein
H-Index: 8
Sabina Signoretti
H-Index: 76
David Braun
H-Index: 12
Paul J Catalano
H-Index: 46
Hans Hammers
H-Index: 42
Novel alternate (Alt) response criteria for early outcome prediction in pancreatic (P) neuroendocrine tumors (NETs): utilizing banked imaging and radiomics
Endocrine Abstracts
2023/12/15
Multi-institutional Characterization of Outcomes for Pediatric and Young Adult Patients With High-Risk Myxopapillary Ependymoma After Radiation Therapy
International Journal of Radiation Oncology* Biology* Physics
2023/12/1
Paul J Catalano
H-Index: 46
Shannon M Macdonald
H-Index: 39
Automated temporalis muscle quantification and growth charts for children through adulthood
Nature Communications
2023/11/9
Genomic Predictors of Leptomeningeal Disease Development among Patients with Brain Metastases
International Journal of Radiation Oncology, Biology, Physics
2023/10/1
A genomic score to predict local control among patients with brain metastases managed with radiation
Neuro-Oncology
2023/10/1
Circulating KIM-1 is a minimally invasive biomarker correlated with treatment response to nivolumab in patients with metastatic renal cell carcinoma.
Oncologist
2023/9/2
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial
The Oncologist
2023/9/1
Development and validation of an automated image-based deep learning platform for sarcopenia assessment in head and neck cancer
JAMA Network Open
2023/8/10
In situ psycho-cognitive assessments support self-determined urban green exercise time
Urban forestry & urban greening
2023/8/1
Paul J Catalano
H-Index: 46
Biomarkers of response to first-line nivolumab therapy in patients with advanced renal cell carcinoma (RCC) enrolled in the HCRN GU16-260 trial.
2023/6/1
Novel use of alternate (Alt) response (Rp) criteria (Cr) for early prediction of outcomes in pancreatic (P) neuroendocrine tumors (NETs): Utilizing banked imaging data from the …
2023/6/1
Plasma KIM-1 for preoperative prediction of renal cell carcinoma versus benign renal masses, and association with clinical outcomes.
2023/6/1
Apollo: A randomized phase II double-blind study of olaparib versus placebo following curative intent therapy in patients with resected pancreatic cancer and a pathogenic BRCA1 …
2023/6/1
Xin Yao
H-Index: 11
Paul J Catalano
H-Index: 46
Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity
Neuro-oncology
2023/6/1
